Abstract:Background: Alzheimer’s disease (AD) is a fatal neurodegenerative disease characterized by progressive cognitive decline and memory loss. However, several therapeutic approaches have shown unsatisfactory outcomes in the clinical setting. Thus, developing alternative therapies for the prevention and treatment of AD is critical. Salidroside (SAL) is critical, an herb-derived phenylpropanoid glycoside compound, has been shown to attenuate lipopolysaccharide (LPS)-induced cognitive impairment. However, the mechanism underlying its neuroprotective effects remains unclear. Here, we show that SAL has a therapeutic effect in the senescence-accelerated mouse prone 8 (SAMP8) strain, a reliable and stable mouse model of AD. Methods: SAMP8 mice were treated with SAL, donepezil (DNP) or saline, and cognitive behavioral impairments were assessed using the Morris water maze (MWM), Y maze, and open field test (OFT). Fecal samples were collected and analyzed by 16S rRNA sequencing on an Illumina MiSeq system. Brain samples were analyzed to detect beta-amyloid (Aβ) 1–42 (Aβ1-42) deposition by immunohistochemistry (IHC) and western blotting. The activation of microglia and neuroinflammatory cytokines was detected by immunofluorescence (IF), western blotting and qPCR. Serum was analyzed by a Mouse High Sensitivity T Cell Magnetic Bead Panel on a Luminex-MAGPIX multiplex immunoassay system. Results: Our results suggest that SAL effectively alleviated hippocampus-dependent memory impairment in the SAMP8 mice. SAL significantly 1) reduced toxic Aβ1-42 deposition; 2) reduced microglial activation and attenuated the levels of the proinflammatory factors IL-1β, IL-6, and TNF-α in the brain; 3) improved the gut barrier integrity and modified the gut microbiota (reversed the ratio of Bacteroidetes to Firmicutes and eliminated Clostridiales and Streptococcaceae, which may be associated with cognitive deficits); and 4) decreased the levels of proinflammatory cytokines, particularly IL-1α, IL-6, IL-17A and IL-12, in the peripheral circulation, as determined by a multiplex immunoassay. Conclusion: In summary, SAL reversed AD-related changes in SAMP8 mice, potentially by regulating the microbiota-gut-brain axis and modulating inflammation in both the peripheral circulation and central nervous system. Our results strongly suggest that SAL has a preventive effect on cognition-related changes in SAMP8 mice and highlight its value as a potential agent for drug development.

Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty

Salvianolic Acid A, a Polyphenolic Derivative from Salvia Miltiorrhiza Bunge, As a Multifunctional Agent for the Treatment of Alzheimer's Disease.

Decrease in the Generation of Amyloid-β Due to Salvianolic Acid B by Modulating BACE1 Activity

Salvianic Borneol Ester Reduces Β-Amyloid Oligomers and Prevents Cytotoxicity.

Salvianolic Acid B, an Antioxidant from Salvia Miltiorrhiza, Prevents A Beta(25-35)-Induced Reduction in Bprp in Pc12 Cells

Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer's disease mouse model through downregulating BACE1 and Aβ generation

Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing Aβ level in Porphyromonas gingivalis -infected mice.

Salvianolic Acid B Ameliorates Retinal Deficits in an Early-Stage Alzheimer’s Disease Mouse Model Through Downregulating BACE1 and Aβ Generation

An in Vitro Study on Probable Inhibition of Cerebrovascular Disease by Salidroside As a Potent Small Molecule Against Induction of Protein Amyloid Fibrils and Cytotoxicity

Insight into the Inhibition Effect of Acidulated Serum Albumin on Amyloid Β-Protein Fibrillogenesis and Cytotoxicity.

Extracts from Chinese herbs with anti-amyloid and neuroprotective activities

Current Progress of Research on Neurodegenerative Diseases of Salvianolic Acid B

Salvianolic Acid B Ameliorates Cognitive Deficits Through IGF-1/Akt Pathway in Rats with Vascular Dementia

Salvianolic Acid B Inhibits the Amyloid Formation of Human Islet Amyloid Polypeptideand Protects Pancreatic Beta-Cells Against Cytotoxicity

Salidroside Attenuates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice and Modulates Inflammation of the Gut-Brain Axis

Neuroprotective Effects of Salidroside in a Mouse Model of Alzheimer’s Disease

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis

N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer's disease with neuroprotective effects

Cryptotanshinione Inhibits Β-Amyloid Aggregation and Protects Damage from Β-Amyloid in SH-SY5Y Cells

Inhibition of Amyloid Β Aggregation and Cytotoxicity by Berbamine Hydrochloride.

Salubrinal Attenuates Β-Amyloid-induced Neuronal Death and Microglial Activation by Inhibition of the NF-κB Pathway